Obu Health review

The catalog is the whole design here: four products, four prices, all visible before you scroll or answer anything, which is more than a good part of this category manages. The two GLP-1 figures sit mid-range with a fifty-dollar gap between them, which is roughly what the difference in compounding cost would predict and therefore reads as a real price rather than a marketing one. If you are comparing sellers on the entry rate this is a straightforward row with nothing hidden behind it — the assessment is free, the physician review is described, and nothing on the page suggests a membership or a separate dispensing charge. The gap is the one that keeps recurring: both figures are floors, no milligram is published, and there is no statement about what happens to the bill as a dose climbs. That matters more than usual on a starting-from price, because a floor with no ceiling and no dose is compatible with almost any structure underneath it — flat pricing, per-dose pricing, or a ladder that steepens. One small detail is worth noticing: one product's figure carries no billing period while the three around it do, which is the kind of inconsistency that makes a catalog harder to trust than the individual numbers in it deserve.

Vs median

$15/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Check plan terms

Obu Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

The catalog is the whole design here: four products, four prices, all visible before a reader scrolls or answers anything, which is more than a good part of this category manages. The two GLP-1 figures sit mid-range with a fifty-dollar gap between them, which is roughly what the difference in compounding cost would predict and therefore reads as a real price rather than a marketing one. For a reader comparing sellers on the entry rate this is a straightforward row with nothing hidden behind it — the assessment is free, the physician review is described, and nothing on the page suggests a membership or a separate dispensing charge. The gap is the one this site keeps finding: both figures are floors, no milligram is published, and there is no statement about what happens to the bill as a dose climbs. That matters more than usual on a starting-from price, because a floor with no ceiling and no dose is compatible with almost any structure underneath it — flat pricing, per-dose pricing, or a ladder that steepens. One small detail on the page is worth noticing as a reader: the NAD+ product's figure carries no billing period while the three around it do, which is the kind of inconsistency that makes a catalog harder to trust than the individual numbers in it deserve.

Both GLP-1 figures are floors with no ceiling and no dose behind them.

• Nothing states whether either price holds as the dose is increased.
• No compounding pharmacy is named anywhere on the site.

Obu Health is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Low dose vs full dose
• The true annual cost of a plan